Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1952-1960

  Stubbe, Hiltrud ^a   Berdoz, José ^a,c   Kraehenbuhl, Jean Pierre ^a   Corthésy, Blaise ^b  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Institut Galli Valerio   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; NEUTRALIZING ANTIBODY; SECRETORY IMMUNOGLOBULIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE RESISTANCE; CELL VACUOLE; CHO CELL; CONTROLLED STUDY; ENTEROCOLITIS; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGLOBULIN VARIABLE REGION; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TIGHT JUNCTION;

EID: 0034651952     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1952     Document Type: Article

References (68)

1. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257.
2. Lyerly, D. M., H. C. Krivan, and T. D. Wilkins. 1988. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1:1.
3. Triadafilopoulos, G., C. Pothoulakis, M. J. O'Brien, and J. T. LaMont. 1987. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 93:273.
4. Lima, A. A., D. M. Lyerly, T. D. Wilkins, D. J. Innes, and R. L. Guerrant. 1988. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect. Immun. 56:582.
5. Riegler, M., R. Sedivy, C. Pothoulakis, G. Hamilton, J. Zacherl, G. Bischof, E. Cosentini, W. Feil, R. Schiessel, J. T. LaMont, and E. Wenzl. 1995. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J. Clin. Invest. 95:2004.
6. Chaves-Olarte, E., M. Weidmann, C. von Eichel-Streiber, and M. Thelestam. 1997. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J. Clin. Invest. 100:1734.
7. Hecht, G., A. Koutsouris, C. Pothoulakis, J. T. LaMont, and J. L. Madara. 1992. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 102:416.
8. Hecht, G., C. Pothoulakis, J. T. LaMont, and J. L. Madara. 1988. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J. Clin. invest. 82:1516.
9. Lyerly, D. M., K. E. Saum, D. K. MacDonald, and T. D. Wilkins. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47:349.
10. Florin, I., and M. Thelestam. 1983. Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. Biochim. Biophys. Acta 763:383.
11. Henriques, B., I. Florin, and M. Thelestam. 1987. Cellular internalization of Clostridium difficile toxin A. Microb. Pathog. 2:455.
12. Pothoulakis, C., R. J. Gilbert, C. Cladaras, I. Castagliuolo, G. Semenza, Y. Hitti, J. S. Montcrief, J. Linevsky, C. P. Kelly, S. Nikulasson, et al. 1996. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J. Clin. Invest. 98:641.
13. Pothoulakis, C., U. Galili, I. Castagliuolo, C. P. Kelly, S. Nikulasson, P. K. Dudeja, T. A. Brasitus, and J. T. LaMont. 1996. A human antibody binds to α-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon. Gastroenterology 110:1704.
14. Smith, J. A., D. L. Cooke, S. Hyde, S. P. Borriello, and R. G. Long. 1997. Clostridium difficile toxin A binding to human intestinal epithelial cells. J. Med. Microbiol. 46:953.
15. Teneberg, S., I. Lonnroth, J. F. Lopez, U. Galili, M. O. Halvarsson, J. Angstrom, J., and K. A. Karlsson. 1996. Molecular mimicry in the recognition of glycosphingolipids by Gal-α-3 Gal-β-4 GlcNac-β-binding Clostridium difficile toxin A human natural anti-α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid non-identical with the animal receptor. Glycobiology 6:599.
16. Castagliuolo, I., M. Riegler, A. Pasha, S. Nikulasson, B. Lu., C. Gerard, N. P. Gerard, and C. Pothoulakis. 1998. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J. Clin. Invest. 101:1547.
17. +-independent cytotoxic effects in cultured normal rat intestinal crypt cells. Infect. Immun. 61:3988.
18. Dillon, S. T., E. J. Rubin, M. Yakubovich, C. Pothoulakis, J. T. LaMont, L. A. Feig, and R. Gilbert. 1995. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect. Immun. 63:1421.
19. Just, I., J. Selzer, M. Wilm, C. von Eichel-Streiher, M. Mann, and K. Aktories. 1995. Glucosylation of rho proteins by Clostridium difficile toxin B. Nature 375: 500.
20. Just, I., J. Selzer, C. von Eichel-Streiber, and K. Aktories. 1995. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J. Clin. Invest. 95:1026.
21. Ciesla, W. P., and D. A. Bohak. 1998. Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities. J. Biol. Chem. 273:16021.
22. Gorbach, S. L., T. W. Chang, and B. Goldin. 1987. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2:1519.
23. Fekety, R., and A. B. Shah. 1993. Diagnosis and treatment of recurrent Clostridium difficile colitis. J. Am. Med. Assoc. 269:71.
24. Buts, J. P., G. Corthier, and M. Delmee. 1993. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J. Pediatr. Gastroenterol. Nutr. 16:419.
25. Kelly, C. P. 1996. Immune response to Clostridium difficile infection. Eur. J. Gastroenterol. Hepatol. 8:1048.
26. Sauerborn, M., P. Leukel, and C. von Eichel-Streiber. 1997. The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol. Lett. 155:45.
27. Ryan, E. T., J. R. Butterton, R. N. Smith, P. A. Carroll, T. I. Crean, and S. B. Calderwood. 1997. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect. Immun. 65:2941.
28. Kelly, C. P., C. Pothoulakis, F. Vavva, I. Castagliuolo, E. F. Bostwick, J. C. O'Keane, S. Keates, and J. T. LaMont. 1996. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins. Antimicrob. Agents Chemother. 40:373.
29. Salcedo, S., S. Keates, C. Pothoulakis, M. Warny, I. Castagliuolo, J. T. LaMont, and C. P. Kelly. 1997. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 41:366.
30. Kink, J. A., and J. A. Williams. 1998. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect. Immun. 66: 2018.
31. Lyerly, D. M., C. J. Phelps, J. Toth, and T. D. Wilkins. 1986. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies Infect. Immun. 54:70.
32. Frey, S. M., and T. D. Wilkins. 1992. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect. Immun. 60: 2488.
33. Kamiya, S., K. Yamakawa, X. Q. Meng, H. Ogura, and S. Nakamura. 1991. Production of monoclonal antibody to Clostridium difficile toxin A which neutralizes enterotoxicity but not haemagglutination activity. FEMS Microbiol. Lett. 65:311.
34. Torres, J. F., and T. P. Monath. 1996. Antigenicity of amino-acid sequences from Clostridium difficile toxin B. J. Med. Microbiol. 44:464.
35. Corthier, G., M. C. Muller, T. D. Wilkins, D. M. Lyerly, and R. L. Haridon. 1991. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect. Immun. 59:1192.
36. 84 human intestinal cell monolayers is pH-dependent. Infect. Immun. 64:3827.
37. Madara, J. L., J. Stafford, D. Barenberg, and S. Carlson. 1988. Functional coupling of tight junctions and microfilaments in T84 monolayers. Am. J. Physiol. 254:G416.
38. Berdoz, J., and J. P. Kraehenbuhl. 1995. Cloning of the rearranged variable regions of mouse immunoglobulin heavy and light chain genes using the polymerase chain reaction. In Animal Cell Technology: Developments Towards the 21st Century. E. C. Beuvery, J. B. Griffiths, and W. P. Teiljemaker, eds. Kluwer, Dordrecht, The Netherlands, p 463.
39. Berdoz, J., C. Tallichet Blanc, M. Remhardt, J. P. Kraehenbuhl, and B. Corthésy. 1999. In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc. Natl. Acad. Sci. USA 96:3029.
40. Anderson, J. M., B. R. Stevenson, L. A. Jesaitis, D. A. Goodenough, and M. S. Mooseker. 1988. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J. Cell Biol. 106:1141.
41. Wilcox, M. H. 1998. Treatment of Clostridium difficile infection. J. Antimicrob. Chemother. 41(Suppl. C):41.
42. Dallas, S. D., and R. D. Rolfe. 1998. Binding of Clostridium difficile toxin A to human milk secretory component. J. Med. Microbiol. 47:879.
43. Rolfe, R. D. 1991. Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters. Infect. Immun. 59:1223.
44. Fleiszig, S. M., D. J. Evans, N. Do, V. Vallas, S. Shin, and K. E. Mostov. 1997. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect. Immun. 65:2861.
45. Wex, C. B. A., G. Koch, and K. Aktories. 1997. Effects of Clostridium difficile toxin B on activation of rat peritoneal mast cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:328.
46. Souza, M., A. A. Melofilho, M. F. G. Rocha, D. M. Lyerly, F. Q. Cunha, A. A. M. Lima, and R. A. Ribeiro. 1997. The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B. Immunology 91:281.
47. Casiagliuolu, I., A. C. Keates, C. C. Wang, A. Pasha, L. Valenick, C. P. Kelly, S. T. Nikulasson, J. T. LaMont, and C. Pothoulakis. 1998. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J. Immunol. 160: 6039.
48. Rocha, M. F. G., M. E. T. Maia, L. Bezerra, D. M. Lyerly, R. L. Guerrant, R. A. Ribeiro, and A. A. M. Lima. 1997. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1-β, tumor necrosis factor α, and leukotrienes. Infect. Immun. 65: 2740.
49. Burakoff, R., L. Zhao, A. J. Celifarco, K. L. Rose, V. Donovan, C. Pothoulakis, and W. H. Percy. 1995. Effects of purified Clostridium difficile toxin A on rabbit distal colon. Gastroenterology 109:348.
50. McGowan, K. L., and H. A. Kader. 1999. Clostridium difficile infection in children. Clin. Microbiol. Newslett. 21:49.
51. Kader, H. A, D. A. Piccoli, A. F. Jawad, K. L. McGowan, and E. S. Mailer. 1998. Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. Gastroenterology 115:1329.
52. Christ, A. D., and R. S. Blumberg. 1997. The intestinal epithelial cell: immunological aspects. Springer Semin. Immunopathol. 18:449.
53. Kelly, C. P., C. Pothoulakis, J. Orellana, and J. T. LaMont. 1992. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 102:35.
54. Kim, K., L. K. Pickering, H. L. DuPont, N. Sullivan, and T. D. Wilkins. 1984. In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. J. Infect. Dis. 150:57.
55. Israel, E. J., S. Taylor, Z. Wu, E. Mizogushi, R. S. Blumberg, A. Bhan, and N. E. Simister. 1997. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92:69.
56. Morton, H. C., M. van Egmond, and J. G. J. van de Winkel. 1996. Structure and function of human IgA Fc receptors (FcaR). Crit. Rev. Immunol. 16:423.
57. Cooke, D. L., and S. P. Borriello. 1998. Nonspecific binding of Clostridium difficile toxin A to murine immunoglobulins via the Fab component. Infect. Immun. 66:1981.
58. Wold, A. E., J. Meslecky, M. Tomana, A. Kobata, H. Ohbayashi, T. Endo, and C. S. Eden. 1990. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58:3073.
59. Rindisbacher, L., S. Cottet, R. Wittek, J. P. Kraehenbuhl, and B. Corthésy. 1995. Production of human secretory component with dimeric IgA binding capacity using viral expression systems. J. Biol. Chem. 270:14220.
60. Lamm, M. E. 1997. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51: 311.
61. Corthésy, B., and J. P. Kraehenbuhl. 1999. Antibody-mediated protection of mucosal surfaces. Curr. Top. Microbiol. Immunol. 236:93.
62. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75.
63. Beagley, K. W., and C. O. Elson. 1992. Cells and cytokines in mucosal immunity and inflammation. Castroenterol. Clin. North Am. 21:347.
64. Torres, J. F., D. M. Lyerly, J. E. Hill, and T. P. Monath. 1995. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect. Immun. 63:4619.
65. Giannasca, P. J., Z. X. Zhang, W. D. Lei, J. A. Boden, M. A. Giel, T. P. Monath, and W. D. Thomas. 1995. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect. Immun. 67:527.
66. Johnson, S., W. D. Sypura, D. N. Gerding, S. L. Ewing, and E. N. Janoff. 1995. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect. Immun. 63:3166.
67. Berneman, A., L. Belec, V. A. Fischetti, and J. P. Bouvet. 1998. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions. Infect. Immun. 66:4163.
68. Taylor, H. P., and N. J. Dimmock. 1985. Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J. Exp. Med. 161:198.